Weisshaar E, Szepietowski JC, Darsow U, et al. European guideline on chronic pruritus. Acta Derm Venereol. 2012;92:563-581.
Ständer S, Weisshaar E, Mettang T, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol. 2007;87:291-294.
Manenti L, Tansinda P, Vaglio A. Uraemic pruritus: clinical characteristics, pathophysiology and treatment. Drugs. 2009;69:251-263.
Paus R, Schmelz M, Biro T, et al. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest. 2006;116:1174-1186.
Steinhoff M, Bienenstock J, Schmelz M, et al. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol. 2006;126:1705-1718.
Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface. QJM. 2003;96:7-26.
Bell PL, Gabriel V. Evidence based review for the treatment of post-burn pruritus. J Burn Care Res. 2009;30:55-61.
Eichenfield LF, Tom WL, Chamlin SL, et al; American Academy of Dermatology. Guidelines of care for the management of atopic dermatitis. Part 1: Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70:338-351.
1. Weisshaar E, Szepietowski JC, Darsow U, et al. European guideline on chronic pruritus. Acta Derm Venereol. 2012;92:563-581.
2. Ständer S, Weisshaar E, Mettang T, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol. 2007;87:291-294.
3. Ständer S, Schäfer I, Phan NQ, et al. Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology. 2010;221:229-235.
4. Dalgard F, Holm JO, Svensson A, et al. Self reported skin morbidity and ethnicity: a population-based study in a Western community. BMC Dermatol. 2007;7:4.
5. Dalgard F, Lien L, Dalen I. Itch in the community: associations with psychosocial factors among adults. J Eur Acad Dermatol Venereol. 2007;21:1215-1219.
6. Ständer S, Streit M, Darsow U, et al. Diagnostic and therapeutic procedures in chronic pruritus [in German]. J Dtsch Dermatol Ges. 2006;4:350-370.
7. Gupta MA, Gupta AK, Kirkby S, et al. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol. 1988;124:1052-1057.
8. Yosipovitch G, Goon A, Wee J, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969-973.
9. Szepietowski JC, Reich A, Wisnicka B. Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat. 2002;10:221-226.
10. Szepietowski JC, Reich A. Pruritus in psoriasis: an update. Eur J Pain. 2016;20:41-46.
11. Manenti L, Tansinda P, Vaglio A. Uraemic pruritus: clinical characteristics, pathophysiology and treatment. Drugs. 2009;69:251-263.
12. Weiss M, Mettang T, Tschulena U, et al. Prevalence of chronic itch and associated factors in haemodialysis patients: a representative cross-sectional study. Acta Derm Venereol. 2015;95:816-821.
13. Szepietowski JC, Sikora M, Kusztal M, et al. Uremic pruritus: a clinical study of maintenance hemodialysis patients. J Dermatol. 2002;29:621-627.
14. Paus R, Schmelz M, Biro T, et al. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest. 2006;116:1174-1186.
15. Sun YG, Zhao ZQ, Meng XL, et al. Cellular basis of itch sensation. Science. 2009;325:1531-1534.
16. Akiyama T, Tominaga M, Takamori K, et al. Roles of glutamate, substance P, and gastrin-releasing peptide as spinal neurotransmitters of histaminergic and nonhistaminergic itch. Pain. 2014;155:80-92.
17. Papoiu AD, Coghill RC, Kraft RA, et al. A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch. Neuroimage. 2012;59:3611-3623.
18. Steinhoff M, Bienenstock J, Schmelz M, et al. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol. 2006;126:1705-1718.
19. Ishiuji Y, Coghill RC, Patel TS, et al. Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. Br J Dermatol. 2009;161:1072-1080.
20. Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface. QJM. 2003;96:7-26.
21. Yosipovitch G, Greaves MW, Fleischer AB, et al. Itch: basic mechanisms and therapy. New York, Basel: Marcel Dekker; 2004.
22. Meyer N, Paul C, Misery L. Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat. Acta Derm Venereol. 2010;90:12-17.
24. Berny-Moreno J, Szepietowski JC. Neuropathic itch caused by nerve root compression: brachioradial pruritus and notalgia paresthetica. Serbian J Dermatol Venereol. 2009;2:68-72.
25. Bell PL, Gabriel V. Evidence based review for the treatment of post-burn pruritus. J Burn Care Res. 2009;30:55-61.
26. Goutos I, Eldardiri M, Khan AA, et al. Comparative evaluation of antipruritic protocols in acute burns: the emerging value of gabapentin in the treatment of burns pruritus. J Burn Care Res. 2010;31:57-63.
27. Andreev VC, Petkov I. Skin manifestations associated with tumours of the brain. Br J Dermatol. 1975;92:675-678.
28. Summers CG, MacDonald JT. Paroxysmal facial itch: a presenting sign of childhood brainstem glioma. J Child Neurol. 1988;3:189-192.
29. Kimyai-Asadi A, Nousari HC, Kimyai-Asadi T, et al. Poststroke pruritus. Stroke. 1999;30:692-693.
31. Shapiro PE, Braun CW. Unilateral pruritus after a stroke. Arch Dermatol. 1987;123:1527-1530.
32. King CA, Huff FJ, Jorizzo JL. Unilateral neurogenic pruritus: paroxysmal itching associated with central nervous system lesions. Ann Intern Med. 1982;97:222-223.
33. Ständer S, Augustin M, Reich A, et al. Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. Acta Derm Venereol. 2013;93:509-514.
34. Ständer S, Blome C, Breil B, et al. Assessment of pruritus - current standards and implications for clinical practice: consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP) [in German]. Hautarzt. 2012;63:521-522, 524-531.
35. Reich A, Heisig M, Phan NQ, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol. 2012;92:497-501.
36. Furue M, Ebata T, Ikoma A, et al. Verbalizing extremes of the visual analogue scale for pruritus: a consensus statement. Acta Derm Venereol. 2013;93:214-215.
37. Grattan CE, Humphreys F; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol. 2007;157:1116-1123.
38. Mirzoyev SA, Davis MD. Brachioradial pruritus: Mayo Clinic experience over the past decade. Br J Dermatol. 2013;169:1007-1015.
40. Eichenfield LF, Tom WL, Chamlin SL, et al; American Academy of Dermatology. Guidelines of care for the management of atopic dermatitis. Part 1: Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70:338-351.
41. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;(suppl 92):44-47.
42. Khalil HM, el Shimi S, Sarwat MA, et al. Recent study of Hymenolepis nana infection in Egyptian children. J Egypt Soc Parasitol. 1991;21:293-300.
43. Wittner M, Tanowitz HB, White AC. Taenia and other tapeworms. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens & practice. 1st ed. Oxford, UK: Churchill Livingstone; 2005:1327-1340.
44. Di Lernia V, Ricci C, Albertini G. Skin eruption associated with Hymenolepis nana infection. Int J Dermatol. 2004;43:357-359.
45. Cuetter AC, Garcia-Bobadilla J, Guerra LG, et al. Neurocysticercosis: focus on intraventricular disease. Clin Infect Dis. 1997;24:157-164.
46. Sunderkötter C, Mayser P, Folster-Holst R, et al. Scabies. J Dtsch Dermatol Ges. 2007;5:424-430.
47. Yancey KB, Egan CA. Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations. JAMA. 2000;284:350-356.
48. Alonso-Llamazares J, Rogers RS 3rd, Oursler JR, et al. Bullous pemphigoid presenting as generalized pruritus: observations in six patients. Int J Dermatol. 1998;37:508-514.
49. Bakker CV, Terra JB, Pas HH, et al. Bullous pemphigoid as pruritus in the elderly: a common presentation. JAMA Dermatol. 2013;149:950-953.
50. Szepietowski JC, Reich A, Schwartz RA. Uraemic xerosis. Nephrol Dial Transplant. 2004;19:2709-2712.
51. Cohen EP, Russell TJ, Garancis JC. Mast cells and calcium in severe uremic itching. Am J Med Sci. 1992;303:360-365.
52. Duque MI, Thevarajah S, Chan YH, et al. Uremic pruritus is associated with higher kt/V and serum calcium concentration. Clin Nephrol. 2006;66:184-191.
54. Diehn F, Tefferi A. Pruritus in polycythaemia vera: prevalence, laboratory correlates and management. Br J Haematol. 2001;115:619-621.
55. Gangat N, Strand JJ, Lasho TL, et al. Pruritus in polycythemia vera is associated with a lower risk of arterial thrombosis. Am J Hematol. 2008;83:451-453.
56. Saini KS, Patnaik MM, Tefferi A. Polycythemia vera-associated pruritus and its management. Eur J Clin Invest. 2010;40:828-834.
57. Caravati CM Jr, Richardson DR, Wood BT, et al. Cutaneous manifestations of hyperthyroidism. South Med J. 1969;62:1127-1130.
58. Weisshaar E, Weiss M, Mettang T, et al. Paraneoplastic itch: an expert position statement of the Special Interest Group (SIG) of the International Forum on the Study of Itch (IFSI). Acta Derm Venereol. 2015;95:261-265.
59. Oaklander AL, Bowsher D, Galer B, et al. Herpes zoster itch: preliminary epidemiologic data. J Pain. 2003;4:338-343.
60. Chabre O, Labat F, Pinel N, et al. Cutaneous lesion associated with multiple endocrine neoplasia type 2A: lichen amyloidosis or notalgia paresthetica? Henry Ford Hosp Med J. 1992;40:245-248.
61. Mazeh D, Melamed Y, Cholostoy A, et al. Itching in the psychiatric ward. Acta Derm Venereol. 2008;88:128-131.
62. Misery L, Alexandre S, Dutray S, et al. Functional itch disorder or psychogenic pruritus: suggested diagnosis criteria from the French Psychodermatology Group. Acta Derm Venereol. 2007;87:341-344.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台